[go: up one dir, main page]

ATE346938T1 - Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen - Google Patents

Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Info

Publication number
ATE346938T1
ATE346938T1 AT99970125T AT99970125T ATE346938T1 AT E346938 T1 ATE346938 T1 AT E346938T1 AT 99970125 T AT99970125 T AT 99970125T AT 99970125 T AT99970125 T AT 99970125T AT E346938 T1 ATE346938 T1 AT E346938T1
Authority
AT
Austria
Prior art keywords
recombinant dna
dna constructs
polyketide synthase
producing compounds
compounds related
Prior art date
Application number
AT99970125T
Other languages
English (en)
Inventor
Christopher Reeves
Daniel Chu
Chaitan Khosla
Daniel Santi
Kai Wu
Original Assignee
Kosan Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kosan Biosciences Inc filed Critical Kosan Biosciences Inc
Application granted granted Critical
Publication of ATE346938T1 publication Critical patent/ATE346938T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/32—Nucleotides having a condensed ring system containing a six-membered ring having two N-atoms in the same ring, e.g. purine nucleotides, nicotineamide-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT99970125T 1998-10-02 1999-10-01 Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen ATE346938T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10274898P 1998-10-02 1998-10-02
US12381099P 1999-03-11 1999-03-11
US13965099P 1999-06-17 1999-06-17

Publications (1)

Publication Number Publication Date
ATE346938T1 true ATE346938T1 (de) 2006-12-15

Family

ID=27379409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99970125T ATE346938T1 (de) 1998-10-02 1999-10-01 Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Country Status (13)

Country Link
US (5) US6503737B1 (de)
EP (1) EP1117801B1 (de)
JP (1) JP2002526114A (de)
KR (1) KR20010085877A (de)
CN (1) CN1329668A (de)
AT (1) ATE346938T1 (de)
AU (2) AU773517B2 (de)
CA (1) CA2343880C (de)
DE (1) DE69934242T2 (de)
IL (1) IL142165A0 (de)
MX (1) MXPA01003376A (de)
NZ (1) NZ510819A (de)
WO (1) WO2000020601A2 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
AU756699B2 (en) 1996-12-03 2003-01-23 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
DE69934242T2 (de) * 1998-10-02 2007-09-20 Kosan Biosciences, Inc., Hayward Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
US6569867B2 (en) 1999-10-01 2003-05-27 Kosan Biosciences, Inc. Polyketide derivatives
ES2335385T3 (es) * 1999-10-13 2010-03-26 The Board Of Trustees Of The Leland Stanford Junior University Biosintesis de sustratos de policetido sintasa.
US6939691B1 (en) 1999-10-13 2005-09-06 Board Of Trustees Of The Leland Stanford Junior University E. coli and Streptomyces host cells that contain MatBC genes or E. coli host cells that contain pcc genes useful for enhanced polyketide production
DE60026563D1 (de) * 1999-10-25 2006-05-04 Kosan Biosciences Inc Herstellung von polyketiden
EP1224300B9 (de) * 1999-10-27 2007-09-26 Kosan Biosciences, Inc. Heterologe herstellung von polyketiden
AU2748701A (en) 1999-10-29 2001-06-06 Kosan Biosciences, Inc. Rapamycin analogs
JP2003523347A (ja) 2000-02-18 2003-08-05 コーサン バイオサイエンシーズ， インコーポレイテッド モチライド化合物
AU2001261432B2 (en) * 2000-05-17 2005-06-16 Kosan Biosciences, Inc. Polyketide derivatives
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
EP1381672A4 (de) * 2001-02-28 2006-01-25 Trustees Of Board Of Biosynthese von polyketidsynthasesubstraten
FR2825717B1 (fr) * 2001-06-08 2005-02-18 Rhodia Chimie Sa Preparation stereoselective de l-acides amines cycliques
US7452692B2 (en) * 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
PL374059A1 (en) * 2002-02-13 2005-09-19 Teva Gyogyszergyar Reszvenytarsasag Method for extracting a macrolide from biomatter
EP1492404B1 (de) 2002-02-19 2011-12-28 Dow AgroSciences LLC Neue spinosyn bildende polyketidsynthasen
US7195907B2 (en) 2002-03-29 2007-03-27 Wyeth Non-ribosomal peptide synthetases and associated biosynthetic genes
AU2003226143A1 (en) 2002-03-29 2003-10-13 Wythe Non-ribosomal peptide synthetases and associated biosynthetic genes
AU2007237187B2 (en) * 2002-07-16 2010-08-05 Biotica Technology Limited Production of polyketides
JP2005532809A (ja) * 2002-07-16 2005-11-04 バイオチカ テクノロジー リミテッド ポリケチド、及び他の天然物の製造
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
JP4791183B2 (ja) * 2002-08-23 2011-10-12 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロン、その中間体、類似体の合成およびその使用
US7799904B2 (en) * 2003-06-13 2010-09-21 University Of Kentucky Research Foundation Gilvocarcin gene cluster, recombinant production and use thereof
US7932083B2 (en) * 2003-11-27 2011-04-26 Mercian Corporation DNA participating in hydroxylation of macrolide compound
FR2869044B1 (fr) * 2004-04-16 2006-07-14 Korea Advanced Inst Sci & Tech Genes pour la synthese de polyketides fr-008
EP1751279A4 (de) * 2004-05-05 2008-03-19 Univ Minnesota An der herstellung von cryptophycin beteiligte nukleinsäuren und polypeptide
AU2005241461B2 (en) * 2004-05-06 2011-04-21 Acco Brands Usa Llc Apparatus and method for determining an optimal ergonomic setup
EP1751286A2 (de) * 2004-06-03 2007-02-14 Wyeth Biosynthetischer gencluster zur herstellung eines komplexen polyketids
EP1770165B1 (de) * 2004-07-20 2011-12-21 Eisai R&D Management Co., Ltd. Für an der biosynthese von pladienolid beteiligtes polypeptid codierende dna
WO2006069386A1 (en) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Method of purifying tacrolimus
US20060154953A1 (en) * 2005-01-05 2006-07-13 Vilmos Keri Amorphous tacrolimus and preparation thereof
TW200716744A (en) * 2005-05-26 2007-05-01 Eisai R&D Man Co Ltd Genetically modified microorganism and process for production of macrolide compound using the microorganism
TW200815458A (en) * 2006-03-15 2008-04-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for purifying Tacrolimus
US7566558B2 (en) * 2006-07-28 2009-07-28 Regents Of The University Of Michigan Nucleic acids and polypeptides involved in the production of cryptophycin
US8759031B2 (en) * 2007-04-12 2014-06-24 Wisconsin Alumni Research Foundation Type I polyketide synthase extender units
EP2272963A1 (de) * 2009-07-09 2011-01-12 LEK Pharmaceuticals d.d. Verfahren zur Herstellung von Tacrolimus
KR101189475B1 (ko) * 2009-12-03 2012-10-15 (주) 제노텍 삼원환 화합물의 생합성을 담당하는 유전자와 단백질
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
US20120196770A1 (en) 2011-01-28 2012-08-02 Amyris, Inc. Gel-encapsulated microcolony screening
CA2834783A1 (en) 2011-05-13 2012-11-22 Amyris, Inc. Methods and compositions for detecting microbial production of water-immiscible compounds
CN103958634B (zh) 2011-09-19 2017-10-10 陶氏环球技术有限责任公司 层型结构件及由其制备的制品
BR112015002724B1 (pt) 2012-08-07 2022-02-01 Total Marketing Services Método para produzir um composto não catabólico heterólogo, e, composição de fermentação
US9121859B2 (en) * 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
JP6595449B2 (ja) 2013-03-15 2019-10-23 アミリス， インコーポレイテッド アセチル補酵素ａ由来化合物を生産するためのホスホケトラーゼおよびホスホトランスアセチラーゼの使用
EP3030662B1 (de) 2013-08-07 2020-01-15 Amyris, Inc. Verfahren zur stabilisierung der herstellung von acetyl-coenzym-a abgeleiteten verbindungen
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
EP3313996A1 (de) 2015-06-25 2018-05-02 Amyris, Inc. Maltoseabhängige degrone, maltosereaktive promotoren, stabilisierungskonstrukte und deren verwendung in der herstellung von nichtkatabolischen verbindungen
JP7411326B2 (ja) 2015-10-01 2024-01-11 ワープ ドライブ バイオ インコーポレイテッド タンパク質－タンパク質インターフェースを分析するための方法および試薬
JP7187318B2 (ja) 2016-04-12 2022-12-12 ギンゴー バイオワークス， インコーポレイテッド 組換え異種ｌａｌを発現する宿主細胞、及び化合物の生産のための方法
EP3532633A4 (de) 2016-10-28 2020-09-09 Ginkgo Bioworks Inc. Zusammensetzungen und verfahren zur herstellung von verbindungen
WO2018081590A1 (en) * 2016-10-28 2018-05-03 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
KR102109168B1 (ko) * 2018-12-11 2020-05-12 인트론바이오테크놀로지 신규 화합물 및 이를 포함하는 진균감염 치료용 약학적 조성물
CN109943545B (zh) * 2019-03-29 2021-08-03 浙江大学 一种酰基转移酶结构域定向改造合成化合物的方法
US11827837B2 (en) * 2019-04-02 2023-11-28 King Fahd University Of Petroleum And Minerals Water-based drilling, completion, and workover fluid composition with reduced barite sagging
EP4054720A1 (de) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras-inhibitoren
JP2022553858A (ja) 2019-11-04 2022-12-26 レボリューション メディシンズ インコーポレイテッド Ｒａｓ阻害剤
CN114867735A (zh) 2019-11-04 2022-08-05 锐新医药公司 Ras抑制剂
EP3822348A1 (de) * 2019-11-12 2021-05-19 Johann Wolfgang Goethe-Universität Frankfurt am Main Adaptersystem artifizieller nichtribosomaler peptidsynthetasen und polyketidsynthasen
EP4214209A1 (de) 2020-09-15 2023-07-26 Revolution Medicines, Inc. Indolderivate als ras-inhibitoren bei der behandlung von krebs
AR125787A1 (es) 2021-05-05 2023-08-16 Revolution Medicines Inc Inhibidores de ras
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras
CN118620933A (zh) * 2024-06-14 2024-09-10 华东理工大学 一种吸水链霉菌子囊亚种的基因工程改造方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US4874748A (en) 1986-03-24 1989-10-17 Abbott Laboratories Cloning vectors for streptomyces and use thereof in macrolide antibiotic production
US5149639A (en) 1986-03-24 1992-09-22 Abbott Laboratories Biologically pure cultures of streptomyces and use thereof in macrolide antibiotic production
ATE120466T1 (de) 1987-12-09 1995-04-15 Fisons Plc Makrozyklische verbindungen.
US5063155A (en) 1988-03-28 1991-11-05 Eli Lilly And Company Method for producing 2"'-o-demethyltylosin
US5098837A (en) 1988-06-07 1992-03-24 Eli Lilly And Company Macrolide biosynthetic genes for use in streptomyces and other organisms
EP0356399A3 (de) 1988-08-26 1991-03-20 Sandoz Ag Substituierte 4-Azatricyclo (22.3.1.04.9) octacos-18-en-Derivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen
CA2044846A1 (en) * 1990-06-25 1991-12-26 Thomas R. Beattie Antagonists of immunosuppressive macrolides
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US5189042A (en) 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
US5712146A (en) 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
EP0725778B1 (de) 1993-09-20 2001-09-26 The Leland Stanford Junior University Rekombinante herstellung von neuen polyketiden
US5672491A (en) 1993-09-20 1997-09-30 The Leland Stanford Junior University Recombinant production of novel polyketides
AU706445B2 (en) 1995-07-06 1999-06-17 Brown University Research Foundation Cell-free synthesis of polyketides
US6033883A (en) 1996-12-18 2000-03-07 Kosan Biosciences, Inc. Production of polyketides in bacteria and yeast
JP2001524829A (ja) 1997-04-30 2001-12-04 コーサン バイオサイエンシーズ，インコーポレイテッド 足場としてモジュラー性ｐｋｓ遺伝子クラスターを使用して生成されるコンビナトリアルなポリケチドライブラリー
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
FR2780774B1 (fr) * 1998-07-03 2001-03-09 Alkan Sa Dispositif d'autoprotection passive pour engin mobile tel qu'un helicoptere
US6150513A (en) 1998-09-16 2000-11-21 Kosan Biosciences, Inc. Polyketide synthase enzymes and recombinant DNA constructs therefor
DE69934242T2 (de) * 1998-10-02 2007-09-20 Kosan Biosciences, Inc., Hayward Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen

Also Published As

Publication number Publication date
IL142165A0 (en) 2002-03-10
CA2343880A1 (en) 2000-04-13
US20030175901A1 (en) 2003-09-18
WO2000020601A3 (en) 2000-10-26
US6503737B1 (en) 2003-01-07
DE69934242T2 (de) 2007-09-20
MXPA01003376A (es) 2002-11-07
KR20010085877A (ko) 2001-09-07
JP2002526114A (ja) 2002-08-20
CN1329668A (zh) 2002-01-02
US7714118B2 (en) 2010-05-11
EP1117801B1 (de) 2006-11-29
AU2004202308A1 (en) 2004-06-24
AU1441500A (en) 2000-04-26
US20090186378A1 (en) 2009-07-23
CA2343880C (en) 2008-08-26
DE69934242D1 (de) 2007-01-11
US20020010328A1 (en) 2002-01-24
NZ510819A (en) 2004-03-26
US6759536B2 (en) 2004-07-06
WO2000020601A2 (en) 2000-04-13
AU773517B2 (en) 2004-05-27
US6660862B2 (en) 2003-12-09
USRE39762E1 (en) 2007-08-07
WO2000020601A9 (en) 2000-08-31
EP1117801A2 (de) 2001-07-25

Similar Documents

Publication Publication Date Title
ATE346938T1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
WO1999057325A3 (en) Enzymes mixture
MXPA02002901A (es) Enzimas de ruta de enfocado lisosomal.
ATE414162T1 (de) Verfahren und materialien zur herstellung von glucosamin
ATE360706T1 (de) Peptidakzeptor ligationsverfahren
EA200400186A1 (ru) Регуляция экспрессии хинолятфосфорибозил-трансферазы
AU2002235994A1 (en) Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same
WO2003012058A3 (en) Media and methods for cultivation of microorganisms
DK1117672T3 (da) Antisense-modulation af survivin-ekpression
BR0014662A (pt) Enzimas as quais desidratam glicerol
DE60313659D1 (de) Borrelidin-derivate und ihre medizinische anwendung
IS6088A (is) Fjölkirnismyndun með framsæknu ensími
FR2804971B1 (fr) Adn codant une acetohydroxyacide synthase, bacterie le contenant et procede de production de l-valine par culture de cette bacterie
DE60036159D1 (de) Für flavonsynthase kodierendes gen
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2004067705A3 (en) Stable lipase variants
AR027256A1 (es) Deteccion de microorganismos relacionados con la fermentacion
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
ATE336582T1 (de) Polyketid-synthasen mit veränderter spezifität, ihre herstellung und verwendung
MY140928A (en) Novel compounds
DE50109809D1 (de) Verfahren zur Herstellung von D- oder L-Menthol
WO2002033093A3 (en) Aggrecanase molecules
WO2004005517A3 (en) L-amidase from rhizobium huautlense
WO2003004607A3 (en) Aggrecanase molecules
ES2164545A1 (es) Enzimas con actividad beta-(1,6)-endoglucanasa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties